{
  "id": "ramesh-balwani",
  "title": "Ramesh Balwani",
  "lang": "en",
  "source_lang": "en",
  "summary": "Ramesh “Sunny” Balwani is a former Theranos executive convicted in 2022 of fraud and conspiracy involving the company’s investors and patients.",
  "category": "economics",
  "subcategory": "business",
  "type": "person",
  "aliases": [
    "Sunny Balwani",
    "Ramesh “Sunny” Balwani"
  ],
  "generated_at": "2026-11-04",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/ramesh-balwani/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/ramesh-balwani/",
      "json": "https://aiwiki.page/zh/ramesh-balwani.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Ramesh “Sunny” Balwani (born 1965) is a businessman who served as president and chief operating officer of Theranos, the American blood-testing company founded by Elizabeth Holmes. He held senior management responsibilities from 2009 to 2016. In July 2022, a federal jury convicted him on all 12 counts of fraud and conspiracy brought against him in connection with the company. He was subsequently sentenced to 155 months in prison."
    },
    {
      "heading": "Business career",
      "text": "Before joining Theranos, Balwani worked in the software industry and was involved with CommerceBid, an e-commerce software business acquired by Commerce One in 1999. He later pursued graduate studies in business and computer science.\n\nBalwani joined Theranos in 2009, several years after its founding. He provided financial support to the company and became a central figure in its management. His responsibilities included oversight of operations, personnel, and the company’s clinical laboratory.\n\nBalwani and Holmes also had a romantic relationship during much of their time working together. Their personal relationship was not publicly disclosed during the company’s rise."
    },
    {
      "heading": "Role at Theranos",
      "text": "Theranos claimed that its proprietary technology could perform a broad range of laboratory tests using very small blood samples. It attracted substantial private investment and established a retail partnership with Walgreens.\n\nSubsequent investigations exposed major discrepancies between these claims and the technology’s actual capabilities. The company relied extensively on conventional laboratory analyzers, and its proprietary testing system had serious reliability problems.\n\nBalwani’s conduct as an executive became the subject of both civil enforcement proceedings and criminal prosecution. The cases concerned representations about the company’s technology, business performance, and testing services."
    },
    {
      "heading": "Civil and criminal proceedings",
      "text": "In March 2018, the U.S. Securities and Exchange Commission brought civil fraud charges against Theranos, Holmes, and Balwani. Holmes and the company agreed to settlements; Balwani did not join those settlements.\n\nFederal prosecutors charged Balwani and Holmes in June 2018. They were ultimately tried separately. Balwani pleaded not guilty, and his defense disputed the prosecution’s characterization of his knowledge and responsibility.\n\nOn July 7, 2022, a jury in the U.S. District Court for the Northern District of California found Balwani guilty of two counts of conspiracy and ten counts of wire fraud. The convictions encompassed schemes to defraud investors and patients. This differed from Holmes’s verdict: her convictions concerned investors, not the patient-related charges.\n\nOn December 7, 2022, Balwani was sentenced to 12 years and 11 months in federal prison, followed by three years of supervised release. In May 2023, the court ordered Balwani and Holmes to pay approximately $452 million in restitution, with joint and several liability. Under that arrangement, the same losses are not recoverable twice; each defendant can be held responsible for the unpaid amount covered by the order."
    }
  ],
  "links": [
    "theranos",
    "elizabeth-holmes",
    "e-commerce",
    "securities-and-exchange-commission",
    "wire-fraud"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}